![]() |
Français |
|
Research at the Institut Curie involves biologists, chemists, physicists, bio-informaticians and clinicians. In Paris and Orsay, in laboratories in partnership with CNRS, Inserm or an university, research work is designed to understand the functioning of normal and cancerous cells. Research topicsMolecular cell Biology and developmental biologyThis important research sector has several teams working exclusively on cell-related issues :
This research draws on the microscopy laboratory's expertise in ultrastructural analysis of cell compartments.
ImmunologyRelationships between biomolecular structure and activity are studied using concepts and instruments derived from physics. When constantly moving proteins interact within a cell, their structures undergo fluctuations which call for detailed analysis. Molecular biophysical also focuses on the imaging of living cells (in vivo) and the molecular analysis of radiation-induced cell damage (radiobiology). The setting up, in Orsay, of a pilot ionic microscopy center specializing in biological research, with a particular focus on oncology, is a major asset for the Institut Curie's work in field. Genetics and OncogenesisIdentifying genome alterations in the human cancers is the basic goal of oncologists working at the Curie Institute, who have pioneered work in this field.Using highly sophisticated tools, they are engaged in detecting major and minor genomic modifications in tumoral cells and identifying genes carrying such alterations. GenotoxicologyGenotoxicology as a discipline is an integral part of the Curie Institute's history. It focuses on the study of interactions between DNA and various substances known as genotoxic agents (ionizing radiation, solar radiation, etc.), as well as on the DNA lesions caused by these agents. Research in this field aims to identify cell mechanisms used to detect and then repair such lesions in order to restore genome integrity.
PharmacochemistryResearch in the field of pharmaceutical chemistry is designed to synthesize anticancer molecules acting specifically on cancer cells without killing healthy cells. This work uses two basic tools, molecular modelling - which allows for the design of tailor-made molecules - and combinatorial chemistry, thanks to which an almost infinite diversity of molecular structures can be developed.Life Physico-chemistryCurie Institute physicists er studying both theoretically and experimentally those organized molecular assemblies that have led to the development of what is known as soft matter. These structures are of particular interest to biologists, as they are involved in the major functions of living organisms, such as cellular mobility and adhesion, or intracellular exchanges. Controlling the migration of cells wich may go on to form distant tumoral metastases is one of the major objectives of this work.
Molecular Mechanisms and oncogenesisIn multicellular organisms, harmonious development and functioning depend upon the quality of the communication established between cells and the environment which sends them signals.Receptors, special molecules located on the cell surface, pick up these signals, which are then amplified, transmitted and integrated into the cell. Cell reponse to the signal received can than take on a variety of different forms, from cell division through cell differentiation. Normal cells have a very complex network of interconnected signalling pathways. The study of cell signalling is essential to the understanding of the pathway problem observed during oncogenesis.
Cellular and Molecular ImagingThe research projects running by the Institut Curie uses powerful imaging techniques to understand better the structural basis of cellular processes implicated in normal and pathological cell proliferation. The Institut Curie has so made available to all its research units technological platforms such as of scientific imaging. Systems biologyInstitut Curie mathematicians, statisticians and computer scientists wholly dedicate their skills and know-how to oncology, and so cancer research has access to state-of-the-art technologies to analyze genetic networks responsible for the development of cancer, and also to IT methodic tools to process and interpret the data. The automation of biological techniques generates vast amounts of data which, to be used effectively, have to be modelized, analyzed, compared and stored. |